Paris Kosti

692 total citations
9 papers, 509 citations indexed

About

Paris Kosti is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Paris Kosti has authored 9 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Paris Kosti's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Neuroblastoma Research and Treatments (2 papers). Paris Kosti is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Neuroblastoma Research and Treatments (2 papers). Paris Kosti collaborates with scholars based in United Kingdom, Switzerland and Ireland. Paris Kosti's co-authors include James N. Arnold, John Maher, Tamara Muliaditan, Cheryl Gillett, James W. Opzoomer, Melita Irving, Denarda Dangaj Laniti, Giorgia Rota, George Coukos and Aodrenn Spill and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Paris Kosti

8 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paris Kosti United Kingdom	7	395	232	185	135	95	9	509
Yansha Sun China	11	517 1.3×	295 1.3×	162 0.9×	148 1.1×	96 1.0×	20	617
Genevieve M. Gerhard United States	5	315 0.8×	250 1.1×	235 1.3×	82 0.6×	84 0.9×	7	621
Aubrey S. Smith United States	11	431 1.1×	317 1.4×	138 0.7×	94 0.7×	77 0.8×	18	560
Cody E. Cotner United States	4	464 1.2×	183 0.8×	136 0.7×	127 0.9×	89 0.9×	10	537
Tobias Riët Germany	9	375 0.9×	217 0.9×	121 0.7×	141 1.0×	106 1.1×	12	490
Marissa Cunetta United States	6	357 0.9×	230 1.0×	78 0.4×	102 0.8×	67 0.7×	6	467
Tania Rodríguez-Cruz United States	10	300 0.8×	189 0.8×	136 0.7×	74 0.5×	49 0.5×	14	397
Greta Maria Paola Giordano Attianese Switzerland	14	565 1.4×	363 1.6×	219 1.2×	85 0.6×	221 2.3×	21	759
Ashwini Balakrishnan United States	5	347 0.9×	114 0.5×	202 1.1×	116 0.9×	91 1.0×	7	448
R. Sonali Majumdar United States	4	478 1.2×	196 0.8×	218 1.2×	127 0.9×	95 1.0×	5	620

Countries citing papers authored by Paris Kosti

Since Specialization

Citations

This map shows the geographic impact of Paris Kosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paris Kosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paris Kosti more than expected).

Fields of papers citing papers by Paris Kosti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paris Kosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paris Kosti. The network helps show where Paris Kosti may publish in the future.

Co-authorship network of co-authors of Paris Kosti

This figure shows the co-authorship network connecting the top 25 collaborators of Paris Kosti. A scholar is included among the top collaborators of Paris Kosti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paris Kosti. Paris Kosti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kosti, Paris, et al.. (2025). Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager. Journal for ImmunoTherapy of Cancer. 13(3). e010063–e010063.

Kosti, Paris, James W. Opzoomer, Rhonda Henley‐Smith, et al.. (2021). Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors. Cell Reports Medicine. 2(4). 100227–100227. 111 indexed citations

Kosti, Paris, et al.. (2021). Generation of hypoxia-sensing chimeric antigen receptor T cells. STAR Protocols. 2(3). 100723–100723. 7 indexed citations

Lanitis, Evripidis, Paris Kosti, Catherine Ronet, et al.. (2021). VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding. Journal for ImmunoTherapy of Cancer. 9(8). e002151–e002151. 38 indexed citations

Kosti, Paris, et al.. (2020). Editor's Pick: Tumour-Associated Hypoxia: Can We Give Chimeric Antigen Receptor T Cells More Breathing Space?. SHILAP Revista de lepidopterología. 1 indexed citations

Lanitis, Evripidis, Giorgia Rota, Paris Kosti, et al.. (2020). Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression. The Journal of Experimental Medicine. 218(2). 119 indexed citations

Muliaditan, Tamara, James W. Opzoomer, Jonathan Caron, et al.. (2018). Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer. Clinical Cancer Research. 24(7). 1617–1628. 50 indexed citations

Kosti, Paris, John Maher, & James N. Arnold. (2018). Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors. Frontiers in Immunology. 9. 1104–1104. 93 indexed citations

Muliaditan, Tamara, Jonathan Caron, James W. Opzoomer, et al.. (2018). Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis. Nature Communications. 9(1). 2951–2951. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact